20 June 2013
Keywords: celltech, anti-tnf, antibody, effective, crohn, disease, therapeutics
Article | 20 November 1995
Celltech Therapeutics has presented the results of a Phase II trial of its antitumor necrosis factor (TNF) antibody in patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.